Josef E. Gillson
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies.
Journal: Advanced drug delivery reviews
Published: April 11, 2025
Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients.
Journal: European journal of clinical investigation
Published: August 13, 2024
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target.
Journal: Cancers
Published: May 13, 2022
Autophagy: A promising target for triple negative breast cancers.
Journal: Pharmacological research
Published: October 22, 2021
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
Journal: Cancers
Published: May 04, 2020
PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression.
Journal: Biochimica et biophysica acta. General subjects
Published: April 28, 2020
NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
Journal: Biochimica et biophysica acta. General subjects
Published: March 06, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026